1-(4-(tert-Butyl)phenyl)-N-methylmethanamine, 95+%, 1g

2-(2,6-DIFLUOROPHENYL)-N-METHOXY-N-METHYLACETAMIDE, 95.0%, 1g

1,3-Diphenylacetone p-tosylhydrazone, 98.0%, 25g

(R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 5g

3'-methoxy-3-(3,4,5-trifluorophenyl)propiophenone, 97.0%, 1g

DDSQ Bis(bicyclo[2.2.1]heptane-2,3-dicarboxylic Dianhydride)>85.0%(qNMR)1g

(S)-N-(2-((2-(2-CYANOPYRROLIDIN-1-YL)-2-OXOETHYL)AMINO)-2-METHYLPROPYL)-2-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXAMIDE, 95.0%, 250mg

N-(2,4-Difluorophenyl)-4,4-dimethyl-3-oxopentanamide, 95.0%, 2g

4-NITROISOQUINOLIN-1(2H)-ONE, 97.0%, 5g

7-(Trifluoromethoxy)quinolin-4-ol, 95.0%, 1g

SDS pellets, 1 kg

2-((tert-Butoxycarbonyl)amino)pent-4-enoic acid, 95.0%, 5g

N1-[3-(Methylthio)phenyl]-2-chloroacetamide, 97.0%, 1g